feed,title,long_url,short_url
Benzinga,FDA Issues Some Concerns Regarding ARS Pharma's Investigational Allergy Treatment,https://benzinga.com/general/biotech/23/05/32297036/fda-issues-some-concerns-regarding-ars-pharmas-investigational-allergy-treatment,https://da.gd/n4QSP
